Results 251 to 260 of about 109,456 (336)

Gut Microbial Variations Associated With Proton Pump Inhibitor Use in the Boston Puerto Rican Health Study

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT Proton pump inhibitors (PPI), used to treat gastrointestinal disorders, are associated with alterations in the gut microbiome. However, this is understudied in Puerto Ricans who have unique lifestyle characteristics. Puerto Ricans, including participants of the Boston‐Puerto Rican Health Study (BPRHS), report high PPI use.
Deepika Dinesh, Xochitl C. Morgan, Hanseul Kim, Tammy M. Scott, Mahdi Garelnabi, Jong Soo Lee, Kelsey M. Mangano, Long H. Nguyen, Curtis Huttenhower, Katherine L. Tucker, Natalia Palacios   +10 more
wiley   +1 more source

Prevalence of Helicobacter pylori and intestinal parasitic coinfections among patients with gastrointestinal complaints in a Rwandan Teaching Hospital. [PDF]

BMC Infect Dis
Munezero A, Ntibaziyaremye E, Musingizimana A, Byagatonda R, Tuyishime O, Umuhoza A, Kayiranga P, Nsengiyumva E, Ndahimana F, Mukantwari E, Nshimiyimana T, Nzitakera A, Rujeni N.   +12 more
europepmc   +1 more source

Androgen Signaling in ILC2s Drives Sex Differences in Helicobacter-induced Gastric Inflammation and Atrophy. [PDF]

Cell Mol Gastroenterol Hepatol
Duncan BC, Morris MT, Pascoe JL, Khadka S, Wang L, Hu G, Busada JT.   +6 more
europepmc   +1 more source

Helicobacter pylori infection Evluated by C14-urea Breath test and it`s Relation with age, sex and ABO/Rhesus blood Groups in Patients with Gastrointestinal complaints in Kirkuk City / Iraq.

, 2019
Nadia. M. Mohammad, Sabah M. Salih
openalex   +1 more source

A Scalable Organoid Model of Urothelial Aging for Metabolic Interrogation, Infection Modeling, and Reversal of Age‐Associated Changes

Aging Cell, Volume 25, Issue 2, February 2026.
mBEDOs: a scalable platform for modeling urothelial aging. mBEDOs derived from aged mouse bladders capture essential molecular and cellular features of urothelial aging and provide a versatile system for high‐throughput metabolic profiling, therapeutic screening via metabolite supplementation, age‐ and sex‐based analyses, infection modeling, and immune–
Adwaita R. Parab, Arnold M. Salazar, Steven J. Bark, Margarita Divenko, Vasanta Putluri, D'Feau J. Lieu, Aadya S. Singh, Nagireddy Putluri, Indira U. Mysorekar   +8 more
wiley   +1 more source

Role of Vonoprazan-Amoxicillin Dual Therapy in Pediatric Refractory <i>Helicobacter Pylori</i> Infection in Children: Early Experience From A Single-Center Case Series. [PDF]

ACG Case Rep J
Cardenas Fernandez MC, Ruiz Arellanos K, Bonilla S.   +2 more
europepmc   +1 more source

Prevalence of Helicobacter pylori Infection in Patients with Central Serous Chorioretinopathy: A Review.

, 2017
Masood Bagheri, Zahra Rashe, Mohammad Hosein Ahoor, Mohammad Hosein Somi   +3 more
openalex   +1 more source

Protective efficacy of recombinant Helicobacter suis proteins against Helicobacter suis challenge in a mouse model [PDF]

, 2012
Ducatelle, Richard, Flahou, Bram, Haesebrouck, Freddy, Pasmans, Frank, Vermoote, Miet   +4 more
core  

Bacterial Toxin Exploits Host Membrane Phospholipid as a Receptor for Binding, Entry, and Cytopathogenicity

Molecular Microbiology, Volume 125, Issue 2, Page 145-158, February 2026.
Mycoplasma pneumoniae pathogenesis relies on its CARDS toxin, which initiates cell binding and subsequent uptake by exploiting sphingomyelin, a key phospholipid found in the host plasma membrane. Maximal cellular entry and full cytotoxic effects are achieved through a synergistic mechanism that involves interaction with the protein coreceptor annexin ...
Alejandra M. Kirkpatrick, Thirumalai R. Kannan   +1 more
wiley   +1 more source

CagA-positive Helicobacter pylori may be associated with current infection of clonorchiasis. [PDF]

Sci Rep
Long C, Lin Z, Cao J, Deng F, Luo Y, Liu Z, Du Q, Pan J, Nong Y, Huang F, He J, Tan S, Lv J.   +12 more
europepmc   +1 more source